Related references
Note: Only part of the references are listed.Long-term persistence of anti-HBs after hepatitis B vaccination among adults: 8-year results
Wen Ren et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Comparison between two population-based hepatitis B serosurveys with an 8-year interval in Shandong Province, China
Jiaye Liu et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Significant reduction in notification and seroprevalence rates of hepatitis B virus infection among the population of Zhejiang Province, China, aged between 1 and 29 years from 2006 to 2014
Yang Zhou et al.
VACCINE (2017)
Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China
Fuqiang Cui et al.
EMERGING INFECTIOUS DISEASES (2017)
Healthy adult vaccination: An urgent need to prevent hepatitis B in China
Yan Qiu et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Responses to hepatitis B vaccine in isolated anti-HBc positive adults
Jun Yao et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
The Global Burden of Liver Disease: The Major Impact of China
Fu-Sheng Wang et al.
HEPATOLOGY (2014)
Update on epidemiology of hepatitis B and C in China
Yan Cui et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Prevalence of Hepatitis B in Insular Regions of Southeast China: A Community-Based Study
Ping Chen et al.
PLOS ONE (2013)
Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity
J. J. Ott et al.
VACCINE (2012)
Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size
Zhuanbo Luo et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2011)
Epidemiological serosurvey of Hepatitis B in China-Declining HBV prevalence due to Hepatitis B vaccination
Xiaofeng Liang et al.
VACCINE (2009)
Assessment of Total Economic Burden of Chronic Hepatitis B (CHB)-Related Diseases in Beijing and Guangzhou, China
Min Hu et al.
VALUE IN HEALTH (2009)
Share Paper
